Dr. Jakubowiak - ASH 2008 - Initial Treatment with Bortezomib (Velcade®), Doxil®, and Dexamethasone (VDD) Is Superior to Thalidomide and Dexamethasone (TD) as Initial Therapy Prior to Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma (MM)
Andrzej Jakubowiak, MD University of Michigan Cancer Center Ann Arbor, Michigan U.S.A.
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.